Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehiro Koganemaru

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2021
[New Armed Antibody"ADC: Antibody-Drug Conjugate"for Solid Tumor]Toshihiko Doi, Shigehiro Koganemaru
Expert Opinion on Biological Therapy|July 28, 2020
Antibody-drug conjugates to treat gastric cancerShigehiro Koganemaru, Kohei Shitara
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
Special Issue: Evaluation of the Antitumor Mechanism of Armed AntibodiesYoshikatsu Koga, Hiroki Takashima, Shigehiro Koganemaru
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Heart failure]Yukinori Ozaki, Shigehiro Koganemaru, Koichi Suyama, et al.
Molecular Cancer Therapeutics|October 25, 2024
Potential Mechanisms of Interstitial Lung Disease Induced by Antibody-Drug Conjugates Based on Quantitative Analysis of Drug DistributionShigehiro Koganemaru, Hirobumi Fuchigami, Chihiro Morizono, et al.
British Journal of Pharmacology|November 15, 2022
Quantitative analysis of drug distribution in heterogeneous tissues using dual-stacking capillary electrophoresis-mass spectrometryShigehiro Koganemaru, Takayuki Kawai, Hirobumi Fuchigami, et al.
BMC Cancer|January 23, 2015
Ewing sarcoma of the liver with multilocular cystic mass formation: a case reportYukinori Ozaki, Yuji Miura, Shigehiro Koganemaru, et al.
Molecular Cancer Therapeutics|August 10, 2019
U3-1402, a Novel HER3-Targeting Antibody-Drug Conjugate, for the Treatment of Colorectal CancerShigehiro Koganemaru, Yasutoshi Kuboki, Yoshikatsu Koga, et al.
Clinical Pharmacology and Therapeutics|October 7, 2023
Quantitative Analysis of the Concentration of Trifluridine in Tumor Hypoxic Regions Using a Novel Platform Combining Functional Endoscopy and Mass SpectrometryShigehiro Koganemaru, Hirobumi Fuchigami, Hiroki Yamashita, et al.
Cancer Science|March 8, 2017
Prognostic value of programmed death-ligand 1 expression in patients with stage III colorectal cancerShigehiro Koganemaru, Naoko Inoshita, Yuji Miura, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2021
[New Armed Antibody"ADC: Antibody-Drug Conjugate"for Solid Tumor]Toshihiko Doi, Shigehiro Koganemaru
Expert Opinion on Biological Therapy|July 28, 2020
Antibody-drug conjugates to treat gastric cancerShigehiro Koganemaru, Kohei Shitara
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
Special Issue: Evaluation of the Antitumor Mechanism of Armed AntibodiesYoshikatsu Koga, Hiroki Takashima, Shigehiro Koganemaru
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Heart failure]Yukinori Ozaki, Shigehiro Koganemaru, Koichi Suyama, et al.
Molecular Cancer Therapeutics|October 25, 2024
Potential Mechanisms of Interstitial Lung Disease Induced by Antibody-Drug Conjugates Based on Quantitative Analysis of Drug DistributionShigehiro Koganemaru, Hirobumi Fuchigami, Chihiro Morizono, et al.
British Journal of Pharmacology|November 15, 2022
Quantitative analysis of drug distribution in heterogeneous tissues using dual-stacking capillary electrophoresis-mass spectrometryShigehiro Koganemaru, Takayuki Kawai, Hirobumi Fuchigami, et al.
BMC Cancer|January 23, 2015
Ewing sarcoma of the liver with multilocular cystic mass formation: a case reportYukinori Ozaki, Yuji Miura, Shigehiro Koganemaru, et al.
Molecular Cancer Therapeutics|August 10, 2019
U3-1402, a Novel HER3-Targeting Antibody-Drug Conjugate, for the Treatment of Colorectal CancerShigehiro Koganemaru, Yasutoshi Kuboki, Yoshikatsu Koga, et al.
Clinical Pharmacology and Therapeutics|October 7, 2023
Quantitative Analysis of the Concentration of Trifluridine in Tumor Hypoxic Regions Using a Novel Platform Combining Functional Endoscopy and Mass SpectrometryShigehiro Koganemaru, Hirobumi Fuchigami, Hiroki Yamashita, et al.
Cancer Science|March 8, 2017
Prognostic value of programmed death-ligand 1 expression in patients with stage III colorectal cancerShigehiro Koganemaru, Naoko Inoshita, Yuji Miura, et al.
Pageof 2